Rashtriya Newsflash

Insulin Resistance Pipeline 2025: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Exscien Corp, Glycomantra, Hanmi Pharma, NorthSea Therapeutics BV

Insulin Resistance Pipeline 2025: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Exscien Corp, Glycomantra, Hanmi Pharma, NorthSea Therapeutics BV

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Insulin Resistance pipeline constitutes 8+ key companies continuously working towards developing 10+ Insulin Resistance treatment therapies, analysis of Clinical Trials,

Read Full Article

From California Retreat to Daily Home Life: EKOUAER Crafts Healing Homewear

Nowadays, many urban women are turning to “healthy retreats” and “daily healing” to alleviate stress. As a result, a set of homewear suitable for long-term relaxation and focused wearing has

Read Full Article

QuasarMD Expands into Full-Body Light Therapy Market with New Recovery Mat

Yorba Linda, California – QuasarMD announced today the launch of its Red Light Therapy Full Body Mat, marking the company’s move from localized light therapy devices into the growing full-body

Read Full Article

Mondressy Unveils Its 2026 Defining Colors: The Five Essential Shades of “Matriarchal Authority and Elegance”

Top 5 color palettes for 2026 spotlight navy blue, champagne, black, dark green, and burgundy for the modern mother-of-the-occasion wardrobe. Mondressy has officially introduced its 2026 defining colors, identifying five

Read Full Article

Motor Neuron Disease Treatment Pipeline Shows Strong Momentum as 180+ Pharma Companies in the Race | DelveInsight

DelveInsight’s, “Motor Neuron Disease Pipeline Insight 2025” report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in Motor

Read Full Article

Metastatic Hormone Refractory Prostate Cancer Clinical Trial Pipeline Expands as 180+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s, “Metastatic Hormone Refractory Prostate Cancer Pipeline Insight 2025” report provides comprehensive insights about 180+ companies and 200+ pipeline drugs

Read Full Article

Non-Hodgkin’s Lymphoma Clinical Trial Pipeline Shows Potential with Active Contributions from 180+ Key Companies | DelveInsight

DelveInsight’s, “Non-Hodgkin Lymphoma Pipeline Insights 2025” report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in Non-Hodgkin Lymphoma

Read Full Article

Ovarian Cancer Clinical Trial Pipeline Accelerates as 180+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s, “Ovarian Cancer Pipeline Insights 2025” report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in the Ovarian

Read Full Article

Interstitial Lung Diseases Clinical Trial Pipeline Gains Momentum: 120+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s “Interstitial Lung Diseases Pipeline Insight 2025” report provides comprehensive insights about 120+ companies and 120+ pipeline drugs in the

Read Full Article

Event Logistics Market to Reach USD 103.89 Billion by 2031, Driven by Digital Coordination, Hybrid Events, and Sustainability Integration

Event Logistics Market Size & Trends | Mordor Intelligence Mordor Intelligence has published a new report on the Event Logistics

Read Full Article